title: Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer?
abstract: BACKGROUND
  To date, for esophageal cancer (EC), the optimal timing of surgical procedures after neoadjuvant chemoradiation (nCRT) is not well defined. Data in rectal cancer suggest that a prolonged interval between treatment and operation may improve tumoral pathologic response, R0 resection rate, and survival. The aims of this study were to evaluate whether delaying operation after nCRT in EC increases pathologic response and has an impact on oncologic outcome or postoperative course.
  
  
  METHODS
  A total of 257 consecutive EC patients (n=161 squamous cell carcinomas and n=96 adenocarcinomas) undergoing nCRT followed by operation between 1997 and 2011 were retrospectively analyzed by the use of prospectively collected data. The patients were divided into two groups according to the median delay between nCRT and operation (<7 weeks, n=122; ≥7 weeks, n=135). The impact of surgical delay on outcomes was studied through univariable and multivariable analyses.
  
  
  RESULTS
  The groups were comparable regarding patient and tumor characteristics (p≥0.074). The ypT0 and R0 resection rates were similar between the two groups, as were postoperative course, median survivals, and incidence and patterns of recurrence (p≥0.332). Multivariable analysis failed to identify any impact of the surgical delay on the endpoints. Subgroup analysis according to the histologic type found similar results.
  
  
  CONCLUSIONS
  After nCRT for EC, delaying operation does not affect the ypT0 rate, postoperative course, or oncologic outcome and cannot therefore be justified by these aims.
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France.
authors: Williams
authors: W
authors: Tessier
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France; Inserm UMR 837, Jean Pierre Aubert Research Center, Lille, France.
authors: Caroline
authors: C
authors: Gronnier
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France; Inserm UMR 837, Jean Pierre Aubert Research Center, Lille, France.
authors: Mathieu
authors: M
authors: Messager
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France; Inserm UMR 837, Jean Pierre Aubert Research Center, Lille, France.
authors: Flora
authors: F
authors: Hec
authors: Academic Radiotherapy Department, CLCC Oscar Lambret Comprehensive Cancer Center, Lille, France; Gastrointestinal Oncology Department, CLCC Oscar Lambret Comprehensive Cancer Center, Lille, France.
authors: Xavier
authors: X
authors: Mirabel
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France.
authors: William B
authors: WB
authors: Robb
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France; Inserm UMR 837, Jean Pierre Aubert Research Center, Lille, France. Electronic address: guillaume.piessen@chru-lille.fr.
authors: Guillaume
authors: G
authors: Piessen
authors: Department of Digestive and Oncologic Surgery, University Hospital Claude Huriez, Centre Hospitalier Régional Universitaire, Lille, France; University of Lille, Nord de France, Lille, France; Inserm UMR 837, Jean Pierre Aubert Research Center, Lille, France.
authors: Christophe
authors: C
authors: Mariette
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery* / Q000628:therapy; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000601:surgery* / Q000628:therapy; D059248:Chemoradiotherapy; D004938:Esophageal Neoplasms / Q000601:surgery* / Q000628:therapy; D016629:Esophagectomy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome